EUVIMEDEUVIMED entdecken
Crossref

Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors

Dan Jia, Xiaoding Shen, Ziyao Wang, Fan Yang, Nengwen Ke iD

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Dan Jia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Outpatient, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Neuroendocrine Tumors, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the association of myosteatosis with survival among patients receiving pancreatectomy for pNETs.

Methods

161 patients were enrolled in this retrospective cohort study. Myosteatosis was evaluated using the mean skeletal muscle attenuation with predefined cut‐off values. The impact of potential risk factors on overall survival (OS) and disease‐free survival (DFS) was assessed using the Kaplan–Meier method and the Cox proportional hazards model. A nomogram was constructed based on preoperative survival predictors, and its predictive performance was evaluated using the Receiver Operating Characteristic curve.

Results

Patients with myosteatosis exhibited significantly worse OS ( p = 0.003) than those without myosteatosis. However, there was no statistically significant difference in DFS between patients with myosteatosis and those without myosteatosis ( p = 0.663). In univariate and multivariate analysis, after adjusting for clinicopathological factors, myosteatosis remained an independent predictor of OS (hazard ratio: 4.65; 95% confidence interval: 1.35–15.96; p = 0.02). A nomogram model, incorporating age, myosteatosis, tumor grading, and N status, demonstrated strong performance in estimating OS.

Conclusion

Myosteatosis independently predicts OS in patients undergoing pancreatectomy for pNETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatectomyPancreatic NeoplasmsNeuroendocrine TumorsMuscle, SkeletalHumansMaleFemaleRetrospective StudiesMiddle AgedAgedNomogramsAdultKaplan-Meier EstimateRisk FactorsProportional Hazards ModelsSurvival RateDisease-Free Survival

Stichwörter der Autor:innen

computed tomographymyosteatosisnomogrampancreatic neuroendocrine tumorssurvival

Autor:innen und Institutionen

  • Department of Outpatient, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Multi-Disciplinary Treatment Group of Neuroendocrine Tumor. West China Hospital, Sichuan University, Chengdu, China.
  • Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Nengwen Ke

Zitieren

APA

Jia, D., Shen, X., Wang, Z., Yang, F., & Ke, N. (2025). Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70222

Vancouver

Jia D, Shen X, Wang Z, Yang F, Ke N. Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70222

BibTeX
@article{Jia2025,
  author = {Jia, Dan and Shen, Xiaoding and Wang, Ziyao and Yang, Fan and Ke, Nengwen},
  title = {Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70222}
}
Kostenlos starten →